Comprehensive Cancer Center Munich (cccm)

This study looks at nerve damage (peripheral neuropathy) in people with advanced bladder cancer who are getting a combination of two drugs, pembrolizumab and enfortumab vedotin, as their first treatment. About 80 participants will be followed for a year to see how often nerve pro…